A Call For Innovative Research From Emerging Investigators.

Posted in DEI Funding Opportunities

Emerging investigators around the world are invited to apply to the The Gilead’s Research Scholars Program in Oncology Solid Tumors. The program selects junior faculty researchers pursuing an academic career at an institution.

Application Deadline: December 6, 2024 at 11:59pm PST
Apply here: Research Scholars Program Solid Tumors Portal
Funding: $180,000 USD paid directly to the researchers’ institution
Read the The Gilead’s Research Scholars program brochure to learn more details and information on the requirements and eligibility.

Scientific Focus:
breast, bladder, upper gastrointestinal (esophageal, gastric, & gastroesophageal junction cancer), or lung cancer that addresses an unmet medical need in the field of Oncology Solid Tumors, in the United States.

Areas of research:

  • Disparities and inequities in cancer care
  • Agnostic approaches to breast, bladder, or lung cancer
  • Combinational drug strategies/approaches to treatment
  • Resistance mechanism identification/novel approaches to addressing resistance mechanisms
  • Transformative, therapeutic modalities/approaches to treatment
  • Patient-specific factors that are predictors of toxicity
  • Genomic polymorphisms and impact treatment response
  • Novel targets and/or biomarkers/imaging techniques
  • Novel diagnostic, prevention and treatment strategies
  • Research to improve Quality of Life (QoL) Patient-Reported Outcomes (PRO’s) e.g., adverse events, addressing unmet needs for patients
  • Any other basic and clinical research that addresses an unmet medical need or gap in scientific knowledge


Eligibility Criteria

  • MD or PhD (or an equivalent degree) at time of award
  • Faculty appointment within the last 7 years in association with a research institution in the United States at the time of application
  • Be an early career investigators only
  • A strong career interest in Oncology Solid Tumors
  • A research mentor with extensive experience in the field of Oncology Solid Tumors
    Able to devote at least 30% of their professional time to research for the next two years
  • Be able to complete the proposed research within the two-year award period